ArticleExperimental hematology & oncology2021

Histological verification of the treatment effect of tirabrutinib for relapsed/refractory primary central nervous system lymphoma.

Yoshiko Okita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.